Article Details

Disitamab Vedotin Conditionally Approved by Chinese Regulator for treatment of Gastric Cancer

Retrieved on: 2021-06-16 00:56:15

Tags for this article:

Click the tags to see associated articles and topics

Disitamab Vedotin Conditionally Approved by Chinese Regulator for treatment of Gastric Cancer. View article details on hiswai:

Excerpt

Antibody-drug Conjugates or ADCs are highly targeted biopharmaceutical drugs that combine monoclonal antibodies specific to surface antigens ...

Article found on: www.oncozine.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up